首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >EXPLORING VISCERAL ADIPOSITY INDEX AS A PREDICTOR OF VISCERAL ADIPOSITY DYSFUNCTION AND EVALUATING ITS PERFORMANCE IN PREDICTING HEPATIC INSULIN RESISTANCE IN INDIAN TYPE 2 DIABETICS
【24h】

EXPLORING VISCERAL ADIPOSITY INDEX AS A PREDICTOR OF VISCERAL ADIPOSITY DYSFUNCTION AND EVALUATING ITS PERFORMANCE IN PREDICTING HEPATIC INSULIN RESISTANCE IN INDIAN TYPE 2 DIABETICS

机译:探索内脏放射性指数作为内脏放射性异常的指标,并评估其在预测印度2型糖尿病患者胰岛素抵抗中的作用

获取原文
       

摘要

Objective: Visceral adiposity index (VAI) is a simple clinical algorithm developed as a surrogate marker for characterizing visceral adiposity dysfunction (VAD). This study aimed to explore an optimal VAI cut off value for predicting VAD as reflected quantitatively by magnetic resonance imaging (MRI) and to evaluate its merit in predicting the severity of the cardiometabolic risk (CMR) in type 2 diabetic patients of India. Methods: Data was collected from 81 diabetics and 48 healthy participants, who underwent metabolic assessments. VAI derived using BMI, waist circumference (WC), triglycerides (TG) and HDLc, was studied against visceral fat area measuring ≥130 cm 2 by MRI as it is associated with higher CMR through raised VAD. Optimal VAI cutoff was determined using the area under the receiver operator characteristic curve (AUROC). Diabetic participants were divided into VAD absent, and VAD present groups based on derived VAI cut off to study associated difference in their metabolic profile. Results: Diabetic group had significantly deranged metabolic profile compared to the healthy control group. M ost of the diabetic group participants had a visceral fat area between 101 and 200 cm 2 . From the ROC curve analysis (AUROC = 0.761), VAI cut-off of 2.0 predicted VAD with sensitivity and specificity of 73.21% and 71.23% respectively. Diabetic participants with VAI values more than 2, had significantly (p<0.05) higher WC, visceral fat, fasting insulin, HOMA-IR (Homeostatic model assessment for insulin resistance), TG (p<0.01), non-HDLc and apolipoprotein B/A1 ratio values. Age adjusted partial correlation analysis showed a significant (p<0.01) positive correlation between VAI and HOMA-IR. Conclusion: VAI was useful in predicting VAD and identifying the severity of CMR within type 2 diabetics. VAI can replace imaging procedures with the advantages of reduced economic burden and can be used as screening tool for surveillance of CMR in Indian population.
机译:目的:内脏脂肪指数(VAI)是一种简单的临床算法,可作为表征内脏脂肪异常(VAD)的替代指标。这项研究旨在探索最佳的VAI临界值,以预测通过磁共振成像(MRI)定量反映的VAD,并评估其在预测印度2型糖尿病患者的心脏代谢风险(CMR)严重程度方面的优点。方法:从81名糖尿病患者和48名健康受试者中收集数据,这些受试者接受了代谢评估。通过BMI,腰围(WC),甘油三酸酯(TG)和HDLc得出的VAI已通过MRI针对≥130cm 2的内脏脂肪区域进行了研究,因为它与升高的VAD与较高的CMR相关。使用接收器操作员特征曲线(AUROC)下的面积确定最佳VAI截止值。糖尿病参与者被分为无VAD组,并根据衍生的VAI划分VAD存在组以研究其代谢谱的相关差异。结果:与健康对照组相比,糖尿病组的代谢曲线明显紊乱。大多数糖尿病组参与者的内脏脂肪面积在101至200 cm 2之间。根据ROC曲线分析(AUROC = 0.761),VAI临界值2.0预测了VAD,其敏感性和特异性分别为73.21%和71.23%。 VAI值大于2的糖尿病参与者,其WC,内脏脂肪,空腹胰岛素,HOMA-IR(胰岛素抵抗稳态模型评估),TG(p <0.01),非HDLc和载脂蛋白B显着(p <0.05)高/ A1比率值。年龄校正的部分相关分析显示VAI与HOMA-IR之间存在显着的正相关(p <0.01)。结论:VAI可用于预测2型糖尿病患者的VAD和确定CMR的严重程度。 VAI可以代替成像程序,具有减轻经济负担的优势,并且可以用作印度人口CMR监测的筛查工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号